A recent clinical study suggested that the inhalation of fibronectin is effective for the treatment of COVID-19, where manifestations of patients showed a dyspnea improvement, cough reduction, sputum reduction, pulmonary exudate reduction, sputum smooth and a decreased CT imaging lesion [51]. This evidence concerns the gene FN1 and COVID-19.